Bosutris Tablets: Uses, Benefits, Side Effects and Safety Information
Description
Product Description: What Are Bosutris Tablets?
Bosutris Tablets are associated with bosutinib, an oral tyrosine kinase inhibitor used in the treatment of certain types of Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML). This blood cancer is characterised by the abnormal growth of white blood cells. Bosutinib works by inhibiting specific proteins involved in the growth and multiplication of leukaemia cells.
Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information and supply-related assistance. Buyers and healthcare professionals seeking information about Bosutris Tablets should verify the product's approved composition, strength, manufacturer, and availability against the actual packaging and official product documentation before ordering.
Bosutris Tablets: Uses and Benefits
Bosutinib is prescribed for eligible patients with specific forms of Ph+ CML, depending on the patient's age, disease stage, previous treatment, and applicable product approval.
Potential clinical benefits include:
Targeted treatment: Bosutinib inhibits specific signalling proteins involved in the growth of leukaemia cells.
Disease management: It helps control certain forms of Ph+ CML when prescribed for an approved indication.
Oral administration: Tablets provide an oral treatment option under specialist supervision.
Individualised treatment planning: Oncologists select the appropriate strength and treatment schedule based on clinical assessment and monitoring.
Treatment outcomes vary between individuals. Bosutris Tablets should not be described as a cure or guaranteed treatment, and they should only be used for the indication approved for the specific product.
Available Strengths and Dosage Information
Bosutinib tablets are available in strengths that may include 100 mg, 400 mg, and 500 mg, depending on the product and market. The availability of these strengths under the Bosutris brand and through Cordium Pharmaceuticals Pvt Ltd must be confirmed before publication.
The prescribed dosage depends on the diagnosis, treatment history, response, tolerability, and liver and kidney function. Patients should follow their oncologist's instructions and must not change the dose, discontinue treatment, or substitute another product without medical advice.
Bosutris Tablets Side Effects
Like other anticancer medicines, bosutinib may cause side effects. Commonly reported adverse effects include:
Diarrhoea
Nausea and vomiting
Abdominal pain
Skin rash
Fatigue and headache
Fever or respiratory tract infections
Changes in liver enzyme levels
Reduced blood cell counts
More serious risks may include liver injury, severe diarrhoea, bleeding, fluid retention, cardiovascular complications, and kidney problems. Contact a healthcare professional promptly if symptoms are severe or persistent. Seek urgent medical attention for serious symptoms such as difficulty breathing, significant bleeding, or severe abdominal pain.
Doctors may recommend regular blood tests and liver and kidney function monitoring throughout treatment.
Important Safety Precautions
Before taking Bosutris Tablets, inform your doctor about existing medical conditions, allergies, pregnancy, breastfeeding, and all medicines or supplements you use. Bosutinib can interact with other medicines, including certain antibiotics, antifungals, and acid-reducing treatments.
Bosutinib may harm an unborn baby. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and appropriate precautions with their healthcare professional. Never self-medicate with prescription anticancer medicines.
Frequently Asked Questions About Bosutris Tablets
1. What is the active ingredient in Bosutris Tablets?
Bosutris 100 mg, 400 mg, and 500 mg products are listed by Indian medicine information sources as containing bosutinib. Confirm the composition and strength on the specific pack before use.
2. What are Bosutris Tablets used for?
Bosutinib is used to treat certain forms of Philadelphia chromosome-positive chronic myeloid leukaemia. Treatment requires specialist supervision.
3. Can Bosutris Tablets cause side effects?
Yes. Diarrhoea, nausea, vomiting, abdominal pain, fatigue, and skin rash are among the reported side effects. Serious reactions are also possible.
4. Can I take Bosutris Tablets without a prescription?
No. Bosutinib is a prescription anticancer medicine and must be taken according to a qualified healthcare professional's instructions.
5. How can I enquire about Bosutris Tablets from Cordium Pharmaceuticals Pvt Ltd?
Contact Cordium Pharmaceuticals Pvt Ltd through its official business channels to confirm product identity, available strengths, regulatory documentation, and authorised supply arrangements.
Contact Cordium Pharmaceuticals Pvt Ltd
For product-related enquiries, request verified product specifications, current availability, and applicable regulatory documentation directly from Cordium Pharma.
